Hookipa Pharma (NASDAQ:HOOK) is a biotechnology company focused on developing a new class of immunotherapeutics based on its proprietary arenavirus platform technologies. The company is dedicated to creating innovative treatments for infectious diseases and cancers, harnessing the power of the immune system to combat these serious conditions. Through its cutting-edge research and development, Hookipa is advancing a diverse pipeline of potential therapies, including novel vaccines and immune-oncology products. The company's objectives revolve around transforming the therapeutic landscape by delivering highly effective, durable, and safe options for patients in need across the globe. With a relentless pursuit of groundbreaking solutions, Hookipa is committed to making a meaningful difference in the lives of those affected by challenging diseases.